Skip to main content

TUDOR INVESTMENT CORP ET AL

Position in KROS — Keros Therapeutics, Inc.

CIK 923093 STAMFORD, CT

Position in KROS

as of Mar 31, 2026 · filed May 15, 2026
Position Value
$309,197
-$267,133 QoQ
Shares Held
28,007
-1.1% QoQ
Ownership
0.141%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
not a current holder
Holding Since
Jun 2022
12 quarters on record
Voting authority Sole 50% Shared 50% None 0%

Common Shares in KROS Over Time

Shares Held

Position Value (USD)

Position in Biotechnology

Healthcare · as of Jun 30, 2026

TUDOR INVESTMENT CORP ET AL holds $411,209,149 across 107 Biotechnology names.

# Ticker Company Shares Value (USD) Open

All Filings in KROS

Export CSV
12 filing rows on record
Report Date Value (USD) Shares
2026-03-31 $309,197 28,007
2025-12-31 $576,330 28,307
2025-09-30 $308,885 19,525
2025-03-31 $202,353 19,858
2024-12-31 $242,689 15,331
2024-09-30 $1,149,031 19,787
2024-06-30 $473,314 10,357
2024-03-31 $1,125,598 17,003
2023-12-31 $375,453 9,443
2023-03-31 $754,338 17,666
2022-09-30 $482,626 12,829
2022-06-30 $336,892 12,193